The Influence of PrEP-Related Stigma and Social Support on PrEP-Use Disclosure among Women Who Inject Drugs and Social Network Members
Marisa Felsher(Merck & Co., Inc., Rahway, NJ, USA (United States)), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Carl A. Latkin(Johns Hopkins University), Karley Dutra(Thomas Jefferson University Hospital), Alexis M. Roth(Drexel University), Brent Monseur(Stanford University)
Cited by 17
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
The neglected health of international migrant workers in the COVID-19 epidemic
|The Lancet Psychiatry|2020|402
Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
|Mycoses|2011|159
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review
|UNC Libraries|2020|111